Skip to main content

Featured

Housing Market Outlook 2026: Prices Stabilizing, Demand Still Weak

  If you've been watching the Canadian housing market and waiting for a clear signal — up, down, or sideways — welcome to 2026, where the answer is stubbornly "sideways." Prices have stopped falling in most regions, but they're not exactly rallying either. Meanwhile, the buyers who were supposed to flood back after rate cuts? Still sitting on the fence. Here's what the data says and what it means for your wallet. 📊 Quick Stats — April 2026 National average home price: $695,412 (+2.2% year-over-year) National benchmark price (MLS HPI): $666,400 (-4.2% year-over-year) Months of inventory: 5.2 (balanced territory) GTA average price: $1,051,969 (-4.9% year-over-year) Bank of Canada policy rate: 2.25% (held steady) 📉 Why Are Prices "Stabilizing" But Not Recovering? Canada's housing market entered 2026 caught between two opposing forces. On one side, the Bank of Canada cut its policy rate from a peak of 5.0% all the way down to 2.25%, which should ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment